The premier international conference on public health policy is the World Health Assembly, organised by the World Health Organisation, which attracts Ministers of Health and other top health officials as well as non-governmental organisations to Geneva every year. This is where the latest trends in public health problems are presented and debated, and action plans for solutions are adopted. This year’s Assembly, which closed on May 24, had 3,500 participants and saw a record number of issues debated and resolutions adopted.
One of the key buzzwords during the Assembly was “universal health coverage” (UHC). This is being promoted by the WHO and several governments as one of the goals for the United Nations’ post-2015 Development Agenda. There is no precise definition for the term, but it is widely taken to mean that everyone should have access to medical treatment and other health services. Inability to pay should not prevent someone from being “covered” by the health system, and people should not become financially burdened in order to receive treatment.
The UHC concept is a great one, similar to the “health for all by the year 2000” slogan that the WHO adopted in the 1980s. The “right to health” is one of the human rights recognised by the United Nations.
Triple Crisis contributor Martin Khor has written recently about the rising problem of antibiotic-resistant bacteria. Here, he is interviewed by The Real News Network producer Lynn Fries about the issue. Khor pulls no punches about the magnitude of the danger, calling it “as serious to human life as the climate change crisis that we are all trying to address and fighting against.” He goes on to address the necessity of government action on antibiotic resistance, as well as the impediments to such action (including a different kind of resistance—from the pharmaceutical industry).
The World Health Organisation’s most comprehensive report to date sounds a warning that we are entering a world where antibiotics have little effect.
The World Health Organisation (WHO) has sounded a warning that many types of disease-causing bacteria can no longer be treated with the usual antibiotics and the benefits of modern medicine are increasingly being eroded.
The comprehensive 232-page report on anti-microbial resistance with data from 114 countries shows how this threat is happening now in every region of the world and can affect anyone in any country.
Antibiotic resistance—when bacteria evolve so that antibiotics no longer work to treat infections—is described by the report as “a problem so serious that it threatens the achievements of modern medicine.”
While political events will no doubt dominate the news in 2014, social issues such as health and environment and coping with the rising cost of living will be just as important in the new year.
Good health is the basis of everything else that is positive in life. Thus, a preview of key social issues in 2014 should begin with health.
In Malaysia, a major concern is the dramatic rise in dengue, with 39,222 cases in 2013, a 90% jump from a year before.
There is a re-emergence of the deadly human variety of avian flu, with 47 deaths from 147 cases in China coming from the new H7N9 strain in April-December last year.
A few years ago there was the expectation that a flu epidemic could sweep through the world, affecting millions of people. The flu pandemic in 2009 killed thousands of people, including in Mexico and Indonesia, but it was fortunately contained. Read the rest of this entry »
Are big companies making use of trade and investment agreements to challenge health policies? Evidence is building up that they do so, with medicine prices going up and tobacco control measures being suppressed.
This issue came up in Parliament last week when International Trade and Industry Minister Datuk Seri Mustapha Mohamed said the government would not allow the Trans- Pacific Partnership Agreement (TPPA) to cause the prices of generic medicines to go up.
He added he would defend existing policies on patents and medicines, and if we don’t agree with some of the terms, we can choose not to sign.
The Indian Supreme Court’s refusal to uphold the patent on Gleevec, the blockbuster cancer drug developed by the Swiss pharmaceutical giant Novartis, is good news for many of those in India suffering from cancer. If other developing countries follow India’s example, it will be good news elsewhere, too: more money could be devoted to other needs, whether fighting AIDS, providing education, or making investments that enable growth and poverty reduction.
But the Indian decision also means less money for the big multinational pharmaceutical companies. Not surprisingly, this has led to an overwrought response from them and their lobbyists: the ruling, they allege, destroys the incentive to innovate, and thus will deal a serious blow to public health globally.
The World in 2013 by The Economist has been out for a while. Got it at the airport this weekend and read a few pieces. Really bad. Nothing new. One piece caught my attention though. On the fiscal cliff and the elections this terrible article says:
“Mr Obama will maintain that his victory, along with continued Democratic control of the Senate, constitute a mandate for his version of deficit reduction. But in fact the elections produced mixed results: Mr Obama narrowly won the popular vote and the Republicans retained their majority in the House of Representatives.”
First, facts; yes the GOP won the House, but Democratic House candidates won more of the popular vote than their Republican counterparts. Redistricting or Gerrymandering is what explains this failure of democracy. Dems probably need more than 55% of the popular vote to win the majority in the House.
We are economists who think that the economy should serve people, the planet and the future.
The United States ranks first in the world in health care spending per person, but only 45th in life expectancy. The average American sees a doctor less often than the average Canadian, the average Briton, or the average resident of most industrial democracies. The average life expectancy of white Americans without a high school degree has fallen since 1990 by three years for men and five years for women.
This paradoxical combination of first-class costs and second-rate performance is a result of a multi-payer health care system whose enormous administrative bureaucracy absorbs nearly one-third of our health care dollars. The aim of this private bureaucracy is to police patients and doctors, not to add value or protect human health.
Today, the United States will choose between a moderate Republican, with a pro-business agenda, or Mitt Romney. Yes President Obama has saved the economy from a 1930s-like catastrophe with a smaller than necessary, but still very effective, fiscal package, and monetary easing has prevented a collapse of the banking and financial sector like the Great Depression one. Yet, his economic views and policies remain to the right of Richard Nixon. Obama agreed with Mr. Romney that government does not create jobs, and has accepted the anti-Keynesian rhetoric regarding the need of reducing the fiscal deficit, even though the recovery has been very slow.
If Obama wins (and I do believe that Nate Silver is right and his chances are greater than Romney’s) we should not simply expect a continuation of the current policies. Yes, Ben Bernanke will maintain interest rates close to zero in nominal terms and continue the gradual Quantitative Easing which, precluding a collapse of the euro and the flight to dollar denominated bonds, will lead to a more depreciated dollar. But the US cannot expect to grow through exports, particularly to developing countries like China (China bashing was one the silliest and most disingenuous issues raised during the campaign).
Lo and behold, Mitt Romney says he will now support parts of the Affordable Care Act, which the Republicans disdainfully call Obamacare. The Financial Times called it a u-turn. My prediction is that the word Obamacare will conjure up the same positive connotations as Medicare now does.